List of Immunotherapy Drugs for Cancer 2025

Immunotherapy enhances the body’s natural defenses by helping the immune system locate and destroy cancer cells, which often evade detection or suppress immune responses. Certain immunotherapies work by tagging cancer cells, making them more visible to immune cells so they can be targeted effectively. Other types stimulate the activity and proliferation of T cells or other immune components, strengthening the immune attack on tumors. By restoring and amplifying immune function, immunotherapy offers a powerful approach to treating cancers that resist conventional therapies.

Credit: Statista

1. Brand Name: Keytruda

  • Generic Name: pembrolizumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Merck

  • 2. Brand Name: Bavencio

  • Generic Name: avelumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: EMD Serono

  • 3. Brand Name: Imfinzi

  • Generic Name: durvalumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: AstraZeneca

  • 4. Brand Name: Kymriah

  • Generic Name: tisagenlecleucel
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Novartis

  • 5. Brand Name: Libtayo

  • Generic Name: cemiplimab-rwlc
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Regeneron/ Sanofi

  • 6. Brand Name: Opdivo

  • Generic Name: nivolumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • Other Information: COMPANY Bristol-Myers Squibb

  • 7. Brand Name: Pomalyst 

    • Generic Name: pomalidomide
    • Mechanism of Action: Not specified
    • FDA Approval Date: Not specified
    • COMPANY: Bristol Myers Squibb/Celgene

    8. Brand Name: Provenge

  • Generic Name: sipuleucel-T
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Dendreon

  • 9. Brand Name: Revlimid

  • Generic Name: lenalidomide
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Celgene

  • 10. Brand Name: Tecartus

  • Generic Name: brexucabtagene autoleucel
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Kite/Gilead Sciences

  • 11. Brand Name: Tecentriq

  • Generic Name: atezolizumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Genentech

  • 12. Brand Name: TICE

  • Generic Name: Bacillus Calmette-Guerin
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Merck/Organon Teknika


  • 13. Brand Name: Yervoy

  • Generic Name: ipilimumab
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Bristol-Myers Squibb

  • 14. Brand Name: Yescarta

  • Generic Name: axicabtagene ciloleucel
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Kite, a Gilead company


  • 15. Brand Name: Thalomid

  • Generic Name: thalidomide
  • Mechanism of Action: Not specified
  • FDA Approval Date: Not specified
  • COMPANY: Celgene

  • Comments

    Labels

    Show more

    Archive

    Show more

    Popular posts from this blog

    Fenbendazole, Ivermectin and Mebendazole Cancer Success Stories: 562 Case Reports Compilation (February 2026 Edition)

    Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

    Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2025)

    Ivermectin, Fenbendazole and Mebendazole Protocol in Cancer: Peer-Reviewed Protocol in Cancer

    Dr William Makis Ivermectin Protocol 2026 – Complete Guide + Patient Outcomes

    DMSO 101: Benefits, Uses, Dosage and Side Effects (2026)

    Best Fenbendazole Dosage for Humans: Safety, Side Effects and Efficacy Examined (2026)

    Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2026)

    Fenbendazole and Ivermectin for Prostate Cancer? A Case Series of 62 Patients (February 2026 Edition)

    Stage 4 Cancer Remissions with Fenbendazole, Ivermectin and Mebendazole: 303 Case Reports Compilation (January 2026 Edition)